Published in Naunyn Schmiedebergs Arch Pharmacol on October 01, 1990
Pharmacological characterization of presynaptic alpha 2-autoreceptors in rat submaxillary gland and heart atrium. Br J Pharmacol (1992) 1.10
Subclassification of release-regulating alpha 2-autoreceptors in human brain cortex. Br J Pharmacol (1992) 0.93
Subclassification of the presynaptic alpha 2-autoreceptors in rabbit brain cortex. Br J Pharmacol (1991) 0.91
Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice. Br J Pharmacol (2001) 0.91
Alpha 2-autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation. Br J Pharmacol (1993) 0.88
Subtype classification of the presynaptic alpha-adrenoceptors which regulate [3H]-noradrenaline secretion in guinea-pig isolated urethra. Br J Pharmacol (1992) 0.79
Investigations of the subtype of alpha 2-adrenoceptor mediating contractions of the human saphenous vein. Br J Pharmacol (1992) 0.75
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement. Cell Mol Life Sci (2005) 1.60
An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J Cell Biol (2001) 1.58
Signaling from Ras to Rac and beyond: not just a matter of GEFs. EMBO J (2000) 1.49
Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine. Br J Pharmacol (1997) 1.15
Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors. Neuropsychopharmacology (2003) 1.14
Reduced binding of 3 H-reserpine to the hearts of 6-hydroxydopamine-pretreated rats. Eur J Pharmacol (1972) 1.10
Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem (2001) 1.08
1,5-Benzodiazepine tricyclic derivatives exerting anti-inflammatory effects in mice by inhibiting interleukin-6 and prostaglandinE(2)production. Pharmacol Res (2001) 1.03
Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.96
Evidence of the involvement of dopamine in the analgesic effect of nefopam. Eur J Pharmacol (1986) 0.95
Notes on buspirone's mechanisms of action. J Clin Psychiatry (1982) 0.94
Reduced serotonin uptake by spontaneously hypertensive rat platelets. Life Sci (1981) 0.90
Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram. J Neuroimmunol (2000) 0.90
Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. J Pharm Pharmacol (1992) 0.89
Chronic treatment with desipramine facilitates its effect on extracellular noradrenaline in the rat hippocampus: studies on the role of presynaptic alpha2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.89
[3H](+)-pentazocine binding to rat brain sigma 1 receptors. Eur J Pharmacol (1994) 0.89
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. J Neurochem (2002) 0.88
Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite (1986) 0.87
Reduction of food intake by manipulation of central serotonin. Current experimental results. Br J Psychiatry Suppl (1989) 0.86
Intracerebroventricular administration of human umbilical cord blood cells delays disease progression in two murine models of motor neuron degeneration. Rejuvenation Res (2011) 0.85
From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake. Ann N Y Acad Sci (1987) 0.85
The repertoire of T-lymphocytes recovered by bronchoalveolar lavage from healthy nonsmokers. Eur Respir J (1996) 0.85
Comparative studies on the anorectic activity of d-fenfluramine in mice, rats, and guinea pigs. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.85
DHEAS inhibits TNF production in monocytes, astrocytes and microglial cells. Neuroimmunomodulation (1997) 0.85
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology (2001) 0.85
Oligoclonality of lung T lymphocytes following exposure to allergen in asthma. J Immunol (1995) 0.84
Glutamate transporters in the spinal cord of the wobbler mouse. Neuroreport (2001) 0.83
Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma. J Allergy Clin Immunol (1997) 0.83
Depletion of circulating allergen-specific TH2 T lymphocytes after allergen exposure in asthma. J Allergy Clin Immunol (1997) 0.83
Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes. Eur J Pharmacol (1993) 0.83
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. J Med Chem (1997) 0.82
Acid-catalysed hydrolysis and benzodiazepine-like properties of 5-(dialkylamino)- and 5-(alkylthio)-substituted 8-chloro-6-phenyl-6H-[1,2,4]triazolol[4,3-a][1,5]benzodiazepines in mice. J Pharm Pharmacol (1998) 0.82
Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific "peripheral-type" benzodiazepine receptor ligands. J Med Chem (1996) 0.82
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies. J Med Chem (1999) 0.82
Proceedings: Brain levels of the potent analgesic etorphine in rats and their functional significance. Br J Pharmacol (1974) 0.81
[Intra-arterial infusion of hydrogen peroxide in radiotherapy of malignant tumors]. Radiol Med (1969) 0.81
Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus? Mol Pharmacol (1996) 0.81
Hepatic protoporphyria is associated with a decrease in ligand binding for the mitochondrial benzodiazepine receptors in the liver. Biochem Pharmacol (1992) 0.81
Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons. Neurosci Lett (2002) 0.81
Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience (1996) 0.81
Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Am J Clin Nutr (1992) 0.81
Nigral dopamine autoreceptors are exclusively of the D2 type: quantitative autoradiography of [125I]iodosulpride and [125I]SCH 23982 in adjacent brain sections. Neuroscience (1988) 0.81
Quantitative autoradiographical analysis of the age-related modulation of central dopamine D1 and D2 receptors. Neuroscience (1990) 0.80
Characterization of the 1H-cyclopentapyrimidine-2,4(1H,3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. J Med Chem (2001) 0.80
Hypericum perforatum L. extract does not inhibit 5-HT transporter in rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.80
Potential antidepressant properties of SR 57746A, a novel compound with selectivity and high affinity for 5-HT1A receptors. Eur J Pharmacol (1994) 0.80
Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. Eur Cytokine Netw (1998) 0.80
Diazepam binding inhibitor (DBI) increases after acute stress in rat. Neuropharmacology (1991) 0.80
Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.80
Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system. Eur J Neurosci (2002) 0.79
Anorectic effect of fenfluramine isomers and metabolites: relationship between brain levels and in vitro potencies on serotonergic mechanisms. Psychopharmacology (Berl) (1985) 0.79
In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters. Pharmacopsychiatry (2001) 0.79
Acute noise stress in rats increases the levels of diazepam binding inhibitor (DBI) in hippocampus and adrenal gland. Psychopharmacology (Berl) (1991) 0.79
Further studies on the mechanism of serotonin-dependent anorexia in rats. Psychopharmacology (Berl) (1980) 0.79
Localization of GABAA and GABAB receptor subtypes on serotonergic neurons. Brain Res (1986) 0.79
Selective changes of receptor binding in brain regions of aged rats. Life Sci (1982) 0.79
p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J Neurochem (1996) 0.79
Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.79
Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat. Neuropharmacology (1989) 0.79
Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists. J Pharmacol Exp Ther (1994) 0.79
Diazepam and desmethyldiazepam differ in their affinities and efficacies at 'central' and 'peripheral' benzodiazepine receptors. J Pharm Pharmacol (1987) 0.79
Neurosteroid levels are increased in vivo after LPS treatment and negatively regulate LPS-induced TNF production. Eur Cytokine Netw (2000) 0.79
Nitric oxide produced by non-motoneuron cells enhances rat embryonic motoneuron sensitivity to excitotoxins: comparison in mixed neuron/glia or purified cultures. J Neurol Sci (2001) 0.79
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the rat. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.79
Profile of in vitro binding affinities of neuroleptics at different rat brain receptors: cluster analysis comparison with pharmacological and clinical profiles. Pharm Res (1989) 0.79
Deprivation of growth hormone-releasing hormone early in the rat's neonatal life permanently affects somatotropic function. Endocrinology (1990) 0.78
A glucocorticoid receptor-independent mechanism for neurosteroid inhibition of tumor necrosis factor production. Eur J Pharmacol (1996) 0.78
Localization of fenfluramine and reserpine in brain regions of rats with extensive degeneration of 5-hydroxytryptaminergic neurons. J Pharm Pharmacol (1980) 0.78
GABAA receptor impairment in the genetic absence epilepsy rats from Strasbourg (GAERS): an immunocytochemical and receptor binding autoradiographic study. Epilepsy Res (1993) 0.78
Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice. Eur J Pharmacol (1996) 0.78
Tumor necrosis factor and motoneuronal degeneration: an open problem. Neuroimmunomodulation (2001) 0.78
Catecholamine receptor binding in rat kidney: effect of aging. Kidney Int (1988) 0.78
Role of transglutaminase in [3H]5-HT release from synaptosomes and in the inhibitory effect of tetanus toxin. Neurochem Int (1996) 0.78
Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain. J Pharmacol Exp Ther (1993) 0.78
Mechanism of action of anxiolytic drugs. Prog Drug Res (1987) 0.77
Critical notes on the specificity of drugs in the study of metabolism and functions of brain monoamines. Int Rev Neurobiol (1988) 0.77
Evidence that it is possible to cause anorexia by increasing release and/or directly stimulating postsynaptic serotonin receptors in the brain. Prog Neuropsychopharmacol (1980) 0.77
Selective reduction of one class of dopamine receptor binding sites in the corpus striatum of aged rats. Brain Res (1982) 0.77
Hyper- and hyposensitivity of central serotonin receptors:[3H]serotonin binding and functional studies in the rat. Brain Res (1980) 0.77
Effect of long term amineptine treatment on pre- and postsynaptic mechanisms in rat brain. Br J Pharmacol (1986) 0.77
Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: relation to blockade of naloxone precipitated jumping by serotonin agonists. Life Sci (1980) 0.77
In vivo persistent binding of 3 H-reserpine to rat brain subcellular components. Eur J Pharmacol (1972) 0.77
Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats. Eur J Pharmacol (1980) 0.77
Effect of acute and chronic administration of buspirone on serotonin and benzodiazepine receptor subtypes in the rat brain: an autoradiographic study. Neuropharmacology (1991) 0.77
Tetanus toxin inhibits depolarization-induced [3H]serotonin release from rat brain cortex synaptosomes. Neurosci Lett (1993) 0.77
Synthesis of 1,2,4-triazole derivatives: binding properties on endothelin receptors. Med Chem (2007) 0.77
Biochemical characterization of a new highly cardioselective beta-adrenoceptor antagonist. J Pharm Pharmacol (1988) 0.77
Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories. Neurol Sci (2004) 0.77
Progress in assessing the role of serotonin in the control of food intake. Clin Neuropharmacol (1988) 0.77
Arachidonic acid inhibits 3H-glutamate uptake with different potencies in rodent central nervous system regions expressing different transporter subtypes. Pharmacol Res (1997) 0.77